Literature DB >> 6749349

Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis.

J S Pedersen, B H Toh, I R Mackay, B D Tait, I D Gust, A Kastelan, N Hadzic.   

Abstract

Regional differences in serological features of chronic active hepatitis (CAH) were assessed from study of unselected patients with CAH, 53 from Zagreb, Yugoslavia and 53 from Melbourne, Australia. A group of 29 patients from Zagreb with chronic persistent hepatitis (CPH) was also included. The serological marker studied was immunofluorescence reactivity to cytoskeletal components, actin cables (AC) and intermediate filaments (IF), these being mostly responsible for the smooth muscle antibody reactivity which occurs in CAH. The Zagreb cases of CAH differed from the Melbourne cases by having a significantly lower frequency of anti-AC (8% vs 55%) and a significantly higher frequency of anti-IF (34% vs 15%), and correspondingly had a higher frequency of markers of hepatitis B virus (HBV) infection (HBsAg, 53% vs 8% and anti-HBc, 72% vs 34%), and a differing HLA profile, with HLA BW35 higher (38% vs 14%) and B8 lower (18% vs 56%). This study illustrates the differences among populations in expression of CAH, in that HBsAg is held to specify the HBV-associated type, and antibody to actin is held to specify the autoimmune type. These differences would be determined in part by environmental influences, notably HBV, and genetic influences, notably HLA, and are reflected by the differing patterns of immunofluorescence reactivity with the cellular cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749349      PMCID: PMC1536609     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Chronic persistent hepatitis. A clinical, serological, and prognostic study.

Authors:  O Dietrichson
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

2.  The specificity of IgG- and IgM-class smooth muscle antibody in the sera of patients with multiple sclerosis and active chronic hepatitis.

Authors:  S A McMillan; M Haire
Journal:  Clin Immunol Immunopathol       Date:  1979-10

Review 3.  HLA and liver disease.

Authors:  A L Eddleston; R Williams
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

4.  Smooth muscle antibodies of actin and "non-actin" specificity.

Authors:  P Kurki; E Linder; A Miettinen; O Alfthan
Journal:  Clin Immunol Immunopathol       Date:  1978-04

5.  Anti-actin stains synapses.

Authors:  B H Toh; H A Gallichio; P L Jeffrey; B G Livett; H K Muller; M N Cauchi; F M Clarke
Journal:  Nature       Date:  1976-12-16       Impact factor: 49.962

6.  Autoantibody to intermediate filaments in viral hepatitis.

Authors:  J S Pedersen; B H Toh; S A Locarnini; I D Gust; G N Shyamala
Journal:  Clin Immunol Immunopathol       Date:  1981-11

Review 7.  Calmodulin--an intracellular calcium receptor.

Authors:  A R Means; J R Dedman
Journal:  Nature       Date:  1980-05-08       Impact factor: 49.962

8.  Intermediate filaments as mechanical integrators of cellular space.

Authors:  E Lazarides
Journal:  Nature       Date:  1980-01-17       Impact factor: 49.962

Review 9.  Smooth muscle autoantibodies and autoantigens.

Authors:  B H Toh
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  HLA and chronic active hepatitis.

Authors:  M C Mazzilli; S Trabace; F D Raimondo; E Gandini; G Visco
Journal:  Digestion       Date:  1977       Impact factor: 3.216

View more
  15 in total

1.  Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection.

Authors:  F Cassani; L Baffoni; E Raise; L Selleri; M Monti; L Bonazzi; F M Gritti; F B Bianchi
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

2.  Evidence of impaired antigen non-specific but normal antigen specific suppressor cell function in children with autoimmune chronic active hepatitis.

Authors:  A Lobo-Yeo; G Mieli-Vergani; G Kenna; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Autoimmunity in chronic liver disease caused by hepatitis delta virus.

Authors:  D Zauli; C Crespi; F B Bianchi; A Craxi; E Pisi
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

4.  Diagnostic criteria of autoimmune chronic liver disease.

Authors:  F Cassani; M Fusconi; L Baffoni; U Volta; M Lenzi; F B Bianchi; E Pisi
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

5.  Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies.

Authors:  F Cassani; M Fusconi; F B Bianchi; L Selleri; L Baffoni; M Lenzi; E Pisi
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

6.  Association of increased immune complexes, platelet IgG and serum IgG in chronic active hepatitis.

Authors:  S L Pfueller; B G Firkin; N Kerlero de Rosbo; A Riglar; I R Mackay
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

7.  Autoantibodies in three populations of Burkitt's lymphoma patients.

Authors:  E Vainio; G M Lenoir; R M Franklin
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

Authors:  F Cassani; L Muratori; P Manotti; M Lenzi; M Fusconi; G Ballardini; L Selleri; U Volta; D Zauli; R Miniero
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

Review 9.  Historical reflections on autoimmune hepatitis.

Authors:  Ian-R Mackay
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

10.  Morphologic examination of mesenchymal cells in healing wounds of normal and tight skin mice.

Authors:  R M Hembry; D H Bernanke; K Hayashi; R L Trelstad; H P Ehrlich
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.